Ozan Pamir - Nov 14, 2025 Form 4 Insider Report for Niagen Bioscience, Inc. (NAGE)

Role
Chief Financial Officer
Signature
/s/ Jeong James Lee, Attorney-in-Fact
Stock symbol
NAGE
Transactions as of
Nov 14, 2025
Transactions value $
$45,616
Form type
4
Date filed
11/17/2025, 08:23 AM
Previous filing
Feb 14, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Pamir Ozan Chief Financial Officer 10900 WILSHIRE BLVD. SUITE 600, LOS ANGELES /s/ Jeong James Lee, Attorney-in-Fact 2025-11-17 0001834681

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NAGE Common Stock Purchase $30.4K +4.46K +153.58% $6.81 7.37K Nov 14, 2025 Direct F1
transaction NAGE Common Stock Purchase $15.2K +2.22K $6.85 2.22K Nov 14, 2025 The reported securities are held by the reporting person's spouse.
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The weighted average purchase price for the transaction reported was $6.81, and the range of prices were between $6.7975 and $6.82, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased at each separate price within the range above will be provided.